160 related articles for article (PubMed ID: 17545554)
21. Orthopaedics: Structural support.
Berglund J
Nature; 2011 Dec; 480(7377):S56-7. PubMed ID: 22169807
[No Abstract] [Full Text] [Related]
22. Treatment of multiple myeloma bone disease: experimental and clinical data.
Papamerkouriou YM; Kenanidis E; Gamie Z; Papavasiliou K; Kostakos T; Potoupnis M; Sarris I; Tsiridis E; Kyrkos J
Expert Opin Biol Ther; 2015 Feb; 15(2):213-30. PubMed ID: 25388648
[TBL] [Abstract][Full Text] [Related]
23. Advances in the biology and treatment of bone disease in multiple myeloma.
Raje N; Roodman GD
Clin Cancer Res; 2011 Mar; 17(6):1278-86. PubMed ID: 21411443
[TBL] [Abstract][Full Text] [Related]
24. Myeloma: diagnosis complications and supportive care.
Morgan G
Hematology; 2012 Apr; 17 Suppl 1():S109-11. PubMed ID: 22507795
[TBL] [Abstract][Full Text] [Related]
25. An Evidence-Based Approach to Myeloma Bone Disease.
Bingham N; Reale A; Spencer A
Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
[TBL] [Abstract][Full Text] [Related]
26. In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Lund T; Gundesen MT; Juul Vangsted A; Helleberg C; Haukås E; Silkjær T; Asmussen JT; Manuela Teodorescu E; Amdi Jensen B; Schmidt Slørdahl T; Nahi H; Waage A; Abildgaard N; Schjesvold F;
Blood Cancer J; 2024 Apr; 14(1):65. PubMed ID: 38622134
[No Abstract] [Full Text] [Related]
27. Bone and paraproteinemias.
Zangari M; Zhan F; Tricot G
Curr Opin Support Palliat Care; 2010 Sep; 4(3):195-9. PubMed ID: 20657285
[TBL] [Abstract][Full Text] [Related]
28. The role of bisphosphonates in multiple myeloma.
Levy J; Roodman GD
Curr Hematol Malig Rep; 2009 Apr; 4(2):108-12. PubMed ID: 20425422
[TBL] [Abstract][Full Text] [Related]
29. Myeloma bone disease and treatment options.
Yeh HS; Berenson JR
Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
[TBL] [Abstract][Full Text] [Related]
30. Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.
Mateos MV; Fink L; Koneswaran N; Intorcia M; Giannopoulou C; Niepel D; Cavo M
BMC Cancer; 2020 Mar; 20(1):170. PubMed ID: 32126974
[TBL] [Abstract][Full Text] [Related]
31. Further analyses of the Myeloma IX Study.
Morgan GJ
Lancet; 2011 Aug; 378(9793):768-9. PubMed ID: 21872746
[No Abstract] [Full Text] [Related]
32. [Management of multiple myeloma-related bone disease].
Jurczyszyn A; Grosicki S; Czerniuk MR; Morga R; Małecki K; Skotnicki AB
Przegl Lek; 2013; 70(11):950-7. PubMed ID: 24697037
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonates for Patients Diagnosed With Multiple Myeloma.
Mhaskar R; Djulbegovic B
JAMA; 2018 Oct; 320(14):1483-1484. PubMed ID: 30326511
[TBL] [Abstract][Full Text] [Related]
34. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Fukunaga M
Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic approaches to myeloma bone disease: an evolving story.
Longo V; Brunetti O; D'Oronzo S; Dammacco F; Silvestris F
Cancer Treat Rev; 2012 Oct; 38(6):787-97. PubMed ID: 22494965
[TBL] [Abstract][Full Text] [Related]
36. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Sanders J; Crawford B; Gibson J; Joy Ho P; Iland H; Joshua D
Int J Lab Hematol; 2007 Oct; 29(5):395-7. PubMed ID: 17824924
[No Abstract] [Full Text] [Related]
37. Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
Lein M; Miller K; Wirth M; Weissbach L; May C; Schmidt K; Haus U; Schrader M; Jung K
Prostate; 2009 May; 69(6):624-32. PubMed ID: 19143027
[TBL] [Abstract][Full Text] [Related]
38. Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
Terpos E; Dimopoulos MA
Lancet Oncol; 2010 Oct; 11(10):913-4. PubMed ID: 20863760
[No Abstract] [Full Text] [Related]
39. Myeloma bone disease.
Berenson JR
Best Pract Res Clin Haematol; 2005; 18(4):653-72. PubMed ID: 16026743
[TBL] [Abstract][Full Text] [Related]
40. Bone Disease in Myeloma: The Claws of CRAB.
Fonseca R; Jain T
Clin Cancer Res; 2016 Mar; 22(6):1301-3. PubMed ID: 26792259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
